Product Information
DISOPYRAMIDE 150 MG CAPSULE is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $1.5318 per EA under NDC 59762040001. Its NADAC has been published 347 times since Jun 12, 2019.
Strength
150 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762040001
Classification
Generic
Dosage Form
CAPSULE, GELATIN COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DISOPYRAMIDE PHOSPHATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA017447On Market Since
4/23/2019
Pharmacological Classes
Price Statistics
The NADAC for DISOPYRAMIDE 150 MG CAPSULE has been published 347 times since Jun 12, 2019, and over the history we have for it it has declined 12.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5318 per EA |
|---|---|
| All-time high | $1.7871 (May 15, 2024) |
| All-time low | $1.0595 (Jan 22, 2025) |
| 52-week high | $1.7091 |
| 52-week low | $1.4367 |
| Median price | $1.4743 |
| Average price | $1.5015 |
| Largest weekly change | -22.9% (Nov 20, 2024) |
| Weeks tracked | 347 |
| Tracking since | Jun 12, 2019 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DISOPYRAMIDE 150 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DISOPYRAMIDE 150 MG CAPSULE, manufactured by Mylan Pharmaceuticals Inc., is $1.5318 per EA (NDC 59762040001), effective Jun 24, 2026.
How has the price of DISOPYRAMIDE 150 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DISOPYRAMIDE 150 MG CAPSULE has declined 12.6%. It has been tracked across 347 weekly CMS publications since Jun 12, 2019.
What are the highest and lowest recorded NADAC prices for DISOPYRAMIDE 150 MG CAPSULE?
Since Jun 12, 2019, the NADAC for DISOPYRAMIDE 150 MG CAPSULE has ranged from a low of $1.0595 (Jan 22, 2025) to a high of $1.7871 (May 15, 2024), with a median of $1.4743 per EA.
Are there cheaper alternatives to DISOPYRAMIDE 150 MG CAPSULE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as DISOPYRAMIDE 150 MG CAPSULE, but none are currently priced below it.
Who manufactures DISOPYRAMIDE 150 MG CAPSULE?
DISOPYRAMIDE 150 MG CAPSULE (NDC 59762040001) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification